Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0014070 (
encephalomyelitis
)
13,017
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
G protein-coupled receptor 65
(
GPR65
) gene has been genetically associated with several autoimmune diseases, including multiple sclerosis (MS).
GPR65
is predominantly expressed in lymphoid organs and is activated by extracellular protons. In this study, we tested whether
GPR65
plays a functional role in demyelinating autoimmune disease. Using a murine model of MS, experimental autoimmune
encephalomyelitis
(EAE), we found that Gpr65-deficient mice develop exacerbated disease. CD4
+
helper T cells are key drivers of EAE pathogenesis, however, Gpr65 deficiency in these cells did not contribute to the observed exacerbated disease. Instead, Gpr65 expression levels were found to be highest on invariant natural killer T (iNKT) cells. EAE severity in Gpr65-deficient mice was normalized in the absence of iNKT cells (CD1d-deficient mice), suggesting that
GPR65
signals in iNKT cells are important for suppressing autoimmune disease. These findings provide functional support for the genetic association of
GPR65
with MS and demonstrate
GPR65
signals suppress autoimmune activity in EAE.
...
PMID:GPR65 inhibits experimental autoimmune encephalomyelitis through CD4
+
T cell independent mechanisms that include effects on iNKT cells. 2954 90